Process for producing poxviruses and poxvirus compositions

Details Process for producing poxviruses and poxvirus compositions Process for producing poxviruses and poxvirus compositions

2007-06-15

2011-11-15

Mosher, Mary E (Department: 1648)

Chemistry: molecular biology and microbiology

Virus or bacteriophage, except for viral vector or...

Recovery or purification

C435S235100

Reexamination Certificate

active

08058049

ABSTRACT:
The present invention relates to compositions and pharmaceutical compositions comprising poxviruses and more particularly extracellular enveloped viruses. The present invention also relates to a process for producing poxviruses and poxviruses obtained thereof. Moreover, the present invention also relates to the use of said poxvirus and said composition for the preparation of a medicament.

REFERENCES:
patent: 7118754 (2006-10-01), Balloul et al.
patent: 2005/0208074 (2005-09-01), Balloul et al.
patent: 2006/0094104 (2006-05-01), Grillberger et al.
patent: 2006/0233834 (2006-10-01), Guehenneux et al.
patent: 2008/0318301 (2008-12-01), Lau
patent: WO 98/04705 (1998-02-01), None
patent: WO 2004/022729 (2004-03-01), None
patent: WO 2005/007840 (2005-01-01), None
patent: WO 2006/045438 (2006-05-01), None
Katz et al (Journal of Virology 71:3178-3187, 1997).
Katz et al (AIDS Research and Human Retroviruses 13:1497-1500, 1997).
Gilbert et al (Cytotechnology 48:79-88, 2005).
VP-SFM brochure. GIBCO Invitrogen Corporation, Carlsbad, CA. © 2002.
Katz et al (Journal of Virology 71:3178-3187, 1997) (in IDS).
Kwak et al (Virology 322:337-348, 2004).
Meiser et al (Journal of General Virology 84:1383-1392, 2003).
Spehner et al (Virology 273:9-15, 2000).
Boulanger et al (Journal of General Virology 81: 675-687, 2000).
Vanderplasschen et al (Journal of Virology 71:4032-4041, 1997).
Katz, Ehud et al., “The Cytoplasmic and Transmembrane Domains of the Vaccinia Virus B5R Protein Target a Chimeric Human Immunodeficiency Virus Type 1 Glycoprotein to the Outer Envelope of Nascent Vaccinia Virions”, Journal of Virology, 1997, pp. 3178-3187, vol. 71, No. 4.
Galmiche, Marie C. et al., “Expression of a functional single chain antibody on the surface of extracellular enveloped vaccinia virus as a step towards selective tumour cell targeting”, Journal of General Virology, Society for General Microbiology, Spencers Wood, GB, Nov. 1997, pp. 3019-3027, vol. 78, No. 11.
Sutter, Gerd et al, “Nonreplicating vaccinia vector efficiently expresses recombinant genes”, Proceedings of the National Academy of Sciences of USA, National Academy of Science, Washington, DC, Nov. 1992, pp. 10847-10851, vol. 89.
Smith, Geoffrey L. et al., “The formation and function of extracellular enveloped vaccinia virus”, Journal of General Virology, Dec. 2002, pp. 2915-2931, vol. 83, No. 12.
Mcintosh, Alison A. G. et al, “Vaccinia Virus Glycoprotein A34R is Required for Infectivity of Extracellular Enveloped Virus”, Journal of Virology, The American Society for Microbiology, Jan. 1996, pp. 272-281, vol. 70, No. 1.
Transgene, “Transgene Announces Positive Phase II Results for its HPV Therapeutic Vaccine in Precancerous Cervical Lesions”, Internet Citation URL:http://www.transgene.fr/us/pdf/communique—presse/communiques—divers—2006/CP-US%20Eurogin%2025-04-06.pdf>, retrieved on Oct. 8, 2007.
Transgene (Squiban P), “Transgene's Therapeutic Vaccine MVA-MUCI-IL2 at ASCO”, Internet Citation URL:http://vvvvw.transgene.com/us/pdf/communique—presse/communiques—divers—2005/PR-US—17-05-2005—ASCO—POUMON.pdf>, retrieved on Oct. 8, 2007.
Trevor, Katrina T. et al., “Transduction of human dendritic cells with a recombinant modified vaccinia Ankara virus encoding MUC1 and IL-2”, Cancer Immunology and Immunotherapy, Berlin, DE, Aug. 22, 2001, pp. 397-407, vol. 50, No. 8.
Written Opinion of the International Searching Authority dated Nov. 5, 2007.
International Preliminary Report on Patentability Jun. 16, 2008.
International Search Report dated Nov. 5, 2007.
Werden, Steven J. Of al., “Poxvirus Host Range Genes,” 71 Advances in Virus Research 135-171 (Jan. 1, 2008).
European Office Action for corresponding European Patent Application No. 07 764 674.3-2405 mailed Aug. 10, 2010.

Affiliated with

Also associated with

Rating

Process for producing poxviruses and poxvirus compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Process for producing poxviruses and poxvirus compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for producing poxviruses and poxvirus compositions will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4258354